Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Following an initial report from Reuters, Merck KGaA confirmed that it is in talks with SpringWorks for a potential ...
As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...
4d
MarketBeat on MSNMerck: 4 No-Brainer Reasons to Buy This DipBig pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the ...
Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...
The Merck Foundation, in collaboration with African First Ladies, celebrates the International Day of Girls and Women in ...
The healthcare pioneer shares insights on transformative diagnostics where precision medicine meets women’s health innovation ...
Merck Foundation Marks International Day of Girls & Women in Science 2025 by providing Over 1000 Scholarships to Women ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results